name:-0.073323011398315
name:-0.047702074050903
name:-0.064044952392578
GW Research Limited Patent Filings

GW Research Limited

Patent Applications and Registrations

Patent applications and USPTO patent grants for GW Research Limited.The latest application filed is for "cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof".

Company Profile
48.66.65
  • GW Research Limited - Cambridge N/A GB
  • GW Research Limited - Histon N/A GB
  • GW Research Limited - Histon, Cambridge, Cambridgeshire GB
  • GW RESEARCH LIMITED - Cambridge, Cambridgeshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Use of cannabinoids in the treatment of epilepsy
Grant 11,446,258 - Guy , et al. September 20, 2
2022-09-20
Cannabinoid Derivatives As Pharmaceutically Active Compounds And Methods Of Preparation Thereof
App 20220288055 - SILCOCK; Alan ;   et al.
2022-09-15
Oral cannabinoid formulations
Grant 11,426,362 - Wright , et al. August 30, 2
2022-08-30
Cannabidiol-type Cannabinoid Compound
App 20220265573 - GUY; Geoffrey ;   et al.
2022-08-25
Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsy
Grant 11,419,829 - Whalley , et al. August 23, 2
2022-08-23
Use Of Cannabidiol In The Treatment Of Epileptic Spasms
App 20220257529 - GUY; Geoffrey ;   et al.
2022-08-18
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20220249396 - GUY; Geoffrey ;   et al.
2022-08-11
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
Grant 11,406,623 - Guy , et al. August 9, 2
2022-08-09
Use of cannabidiol in the treatment of epilepsy
Grant 11,400,055 - Guy , et al. August 2, 2
2022-08-02
Cannabinoid Formulations
App 20220233495 - SILCOCK; Alan ;   et al.
2022-07-28
Use Of Cannabinoids In The Treatment Of Comorbidities Associated With Epilepsy
App 20220226257 - GUY; Geoffrey ;   et al.
2022-07-21
Pharmaceutical formulation
Grant 11,390,437 - Whittle July 19, 2
2022-07-19
Cannabinoid Formulations
App 20220211629 - WILKHU; Jitinder ;   et al.
2022-07-07
Cannabinoids In The Treatment Of Epilepsy
App 20220202738 - GUY; Geoffrey ;   et al.
2022-06-30
Use Of Cannabidiol In The Treatment Of Dravet Syndrome
App 20220184000 - GUY; Geoffrey ;   et al.
2022-06-16
Use of cannabinoids in the treatment of epilepsy
Grant 11,357,741 - Guy , et al. June 14, 2
2022-06-14
Cannabidiol Preparations And Its Uses
App 20220168266 - GUY; Geoffrey ;   et al.
2022-06-02
Use of cannabinoids in the treatment of epilepsy
Grant 11,311,498 - Guy , et al. April 26, 2
2022-04-26
Oral cannabinoid formulations
Grant 11,291,631 - Shah April 5, 2
2022-04-05
Parenteral Formulations
App 20220096397 - WRIGHT; Stephen ;   et al.
2022-03-31
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20220087951 - KNAPPERTZ; Volker
2022-03-24
7-oh-cannabidiol (7-oh-cbd) And/or 7-oh-cannabidivarin (7-oh-cbdv) For Use In The Treatment Of Epilepsy
App 20220062197 - STOTT; Colin ;   et al.
2022-03-03
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20220062211 - STOTT; Colin ;   et al.
2022-03-03
Methods Of Treating Tuberous Sclerosis Complex With Cannabidiol And Everolimus
App 20220040155 - GUY; Geoffrey ;   et al.
2022-02-10
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20220023232 - GUY; Geoffrey ;   et al.
2022-01-27
Parenteral formulations
Grant 11,229,612 - Wright , et al. January 25, 2
2022-01-25
Cannabidiol-type Cannabinoid Compound
App 20220016048 - GUY; Geoffrey ;   et al.
2022-01-20
Use Of Cannabinolids In The Treatment Of Epilepsy
App 20220008355 - GUY; Geoffrey ;   et al.
2022-01-13
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20220000800 - Guy; Geoffrey ;   et al.
2022-01-06
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20210401771 - GUY; Geoffrey ;   et al.
2021-12-30
Cannabidiol preparations and its uses
Grant 11,207,292 - Guy , et al. December 28, 2
2021-12-28
pH dependent release coated microparticle cannabinoid formulations
Grant 11,160,757 - Wilkhu , et al. November 2, 2
2021-11-02
Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
Grant 11,160,795 - Guy , et al. November 2, 2
2021-11-02
Use Of Cannabidiol In The Treatment Of Epilepsy
App 20210330636 - GUY; Geoffrey ;   et al.
2021-10-28
Use of cannabinoids in the treatment of epilepsy
Grant 11,154,516 - Guy , et al. October 26, 2
2021-10-26
Use of cannabinoids in the treatment of epilepsy
Grant 11,154,517 - Guy , et al. October 26, 2
2021-10-26
Use of cannabinoids in the treatment of epilepsy
Grant 11,147,783 - Stott , et al. October 19, 2
2021-10-19
7-OH-cannabidiol (7-OH-CBD) and/or 7-OH-cannabidivarin (7-OH-CBDV) for use in the treatment of epilepsy
Grant 11,147,776 - Stott , et al. October 19, 2
2021-10-19
Combination Of Cannabinoids In The Treatment Of Leukaemia
App 20210308072 - Wright; Stephen ;   et al.
2021-10-07
Use Of Cannabidiol In The Treatment Of Epilepsy
App 20210290565 - GUY; Geoffrey ;   et al.
2021-09-23
Methods Of Treating Tuberous Sclerosis Complex With Cannabidiol And Everolimus
App 20210267950 - GUY; Geoffrey ;   et al.
2021-09-02
Use of cannabinoids in the treatment of epilepsy
Grant 11,096,905 - Guy , et al. August 24, 2
2021-08-24
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20210244685 - Guy; Geoffrey ;   et al.
2021-08-12
Use of cannabinoids in the treatment of multiple myeloma
Grant 11,065,227 - Stott , et al. July 20, 2
2021-07-20
Use of cannabidiol in the treatment of epilepsy
Grant 11,065,209 - Guy , et al. July 20, 2
2021-07-20
Use Of Cannabidiolic Acid In The Treatment Of Autism Spectrum Disorder And Associated Disorders
App 20210205262 - GUY; Geoffrey ;   et al.
2021-07-08
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20210196651 - GUY; Geoffrey ;   et al.
2021-07-01
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20210177773 - GUY; Geoffrey ;   et al.
2021-06-17
Use Of Cannabinoids In The Treatment Of Seizures As Associated With Lennox-gastaut Syndrome
App 20210169824 - GUY; Geoffrey ;   et al.
2021-06-10
Use Of Cannabidiol In The Treatment Of Epilepsy
App 20210145765 - GUY; Geoffrey ;   et al.
2021-05-20
Combination of cannabinoids in the treatment of leukaemia
Grant 11,000,486 - Wright , et al. May 11, 2
2021-05-11
Use of cannabinoids in the treatment of epilepsy
Grant 10,966,939 - Guy , et al. April 6, 2
2021-04-06
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20210093581 - GUY; Geoffrey ;   et al.
2021-04-01
Use Of Cannabinoids In The Treatment Of A Neurodegenerative Disease Or Disorder
App 20210077455 - Whalley; Benjamin ;   et al.
2021-03-18
Modified Release Composition Comprising A Cannabinoid
App 20210059949 - WILKHU; Jitinder ;   et al.
2021-03-04
Oral Pharmaceutical Formulation Comprising Cannabinoids And Poloxamer
App 20210059976 - WILKHU; Jitinder ;   et al.
2021-03-04
Pharmaceutical Composition Comprising A Cannabinoid
App 20210059960 - WILKHU; Jitinder ;   et al.
2021-03-04
Cannabidiol Preparations And Its Uses
App 20210052512 - GUY; Geoffrey ;   et al.
2021-02-25
Use of cannabidiol in the treatment of epilepsy
Grant 10,918,608 - Guy , et al. February 16, 2
2021-02-16
Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders
Grant 10,898,462 - Guy , et al. January 26, 2
2021-01-26
Cannabidiol Preparations And Its Uses
App 20210015789 - GUY; Geoffrey ;   et al.
2021-01-21
Use of cannabinoids in the treatment of epilepsy
Grant 10,849,860 - Guy , et al. December 1, 2
2020-12-01
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200368179 - GUY; Geoffrey ;   et al.
2020-11-26
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200323792 - GUY; Geoffrey ;   et al.
2020-10-15
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200297656 - GUY; Geoffrey ;   et al.
2020-09-24
Use of cannabidiol in the treatment of epilepsy
Grant 10,765,643 - Guy , et al. Sep
2020-09-08
Use Of Cannabidiol In Combination With 5-ht2b Receptor Agonists Or Amphetamins In The Treatment Of Epilepsy
App 20200237683 - WHALLEY; Benjamin ;   et al.
2020-07-30
Use of cannabinoids in the treatment of epilepsy
Grant 10,709,671 - Guy , et al.
2020-07-14
Use of cannabinoids in the treatment of epilepsy
Grant 10,709,674 - Guy , et al.
2020-07-14
Use of cannabinoids in the treatment of epilepsy
Grant 10,709,673 - Guy
2020-07-14
7-oh-cannabidiol (7-oh-cbd) And/or 7-oh-cannabidivarin (7-oh-cbdv) For Use In The Treatment Of Epilepsy
App 20200206152 - Stott; Colin ;   et al.
2020-07-02
Use Of Cannabidiol In The Treatment Of Tuberous Sclerosis Complex
App 20200206153 - WHALLEY; Benjamin ;   et al.
2020-07-02
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200179303 - GUY; Geoffrey ;   et al.
2020-06-11
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200138738 - GUY; Geoffrey ;   et al.
2020-05-07
Use of cannabinoids in the treatment of epilepsy
Grant 10,603,288 - Guy , et al.
2020-03-31
Use of cannabinoids in the treatment of epilepsy
Grant 10,583,096 - Guy , et al.
2020-03-10
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200069608 - Guy; Geoffrey ;   et al.
2020-03-05
Combination Of Cannabinoids In The Treatment Of Leukaemia
App 20200022925 - Wright; Stephen ;   et al.
2020-01-23
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20200000741 - Guy; Geoffrey ;   et al.
2020-01-02
Oral Cannabinoid Formulations
App 20190365667 - WRIGHT; Stephen ;   et al.
2019-12-05
Use Of Cannabinoids In The Treatment Of Angelman Syndrome
App 20190321307 - Guy; Geoffrey ;   et al.
2019-10-24
Parenteral Formulations
App 20190314296 - Wright; Stephen ;   et al.
2019-10-17
Use Of Cannabinoids In The Treatment Of Multiple Myeloma
App 20190175547 - STOTT; Colin ;   et al.
2019-06-13
Oral Cannabinoid Formulations
App 20190167583 - Shah; Harshit
2019-06-06
Use Of Cannabidivarin In The Treatment Of Autism Spectrum Disorder, Associated Disorders And Schizophrenia
App 20190160023 - GUY; Geoffrey ;   et al.
2019-05-30
Use Of Cannabidiolic Acid In The Treatment Of Autism Spectrum Disorder And Associated Disorders
App 20190117619 - GUY; Geoffrey ;   et al.
2019-04-25
Use of Cannabinoids in the Treatment of Epilepsy
App 20190091171 - Guy; Geoffrey ;   et al.
2019-03-28
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20190083418 - Guy; Geoffrey ;   et al.
2019-03-21
Use of cannabinoids in the treatment of degenerative skeletal muscle diseases
Grant 10,226,433 - Di Marzo , et al.
2019-03-12
Use Of Cannabidivarin In The Treatment Of Autism Spectrum Disorder, Associated Disorders And Schizophrenia
App 20190070128 - GUY; Geoffrey ;   et al.
2019-03-07
Synergistic therapies of cannabidiol with hypothermia for neuroprotection
Grant 10,220,005 - Martinez-Orgado , et al.
2019-03-05
Use of phytocannabinoids in the treatment of ovarian carcinoma
Grant 10,098,867 - Javid , et al. October 16, 2
2018-10-16
7-hydroxy cannabidiol (7-OH-CBD) for use in the treatment of non-alcoholic fatty liver disease (NAFLD)
Grant 10,039,724 - Stott , et al. August 7, 2
2018-08-07
Cannabinoid Formulations
App 20180071210 - WILKHU; Jitinder ;   et al.
2018-03-15
Use Of Cannabinoids In The Treatment Of Epilepsy
App 20170007551 - Guy; Geoffrey ;   et al.
2017-01-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed